Targeting cGAS/STING signaling-mediated myeloid immune cell dysfunction in TIME

Vijay Kumar1, Caitlin Bauer2, John H Stewart3,4,5

  • 1Department of Interdisciplinary Oncology, Stanley S. Scott Cancer Center, School of Medicine, Louisiana State University Health Science Center (LSUHSC), 1700 Tulane Avenue, New Orleans, LA, 70012, USA. vkuma2@lsuhsc.edu.

PubMed

Insights

Myeloid immune cells (MICs) detect cellular changes via pattern recognition receptors (PRRs). This review explores how cGAS/STING signaling in MICs impacts the tumor microenvironment (TME) and offers immunotherapy strategies.

Area of Science:

  • Immunology
  • Oncology
  • Cellular Biology

Background:

  • Myeloid immune cells (MICs) are crucial first responders to pathogens and cellular homeostasis disruptions.
  • Cancer involves altered homeostasis, with MICs recognizing these changes through pattern recognition receptors (PRRs).
  • Cytosolic PRRs, like cGAS/STING, detect double-stranded DNA (dsDNA), with longer dsDNA triggering stronger signaling.

Purpose of the Study:

  • To discuss tumor-supportive alterations in MICs within the tumor microenvironment (TME).
  • To emphasize the role of cGAS/STING signaling in modifying the tumor immune microenvironment (TIME).
  • To explore the potential of modulating MIC-specific cGAS/STING signaling for cancer immunotherapy.

Main Methods:

  • Review of existing literature on MICs, PRRs, and cGAS/STING signaling in cancer.
  • Analysis of how cGAS/STING activation influences the TME.
  • Discussion of therapeutic strategies targeting cGAS/STING in MICs.

Main Results:

  • cGAS/STING signaling in MICs can promote tumor growth by altering the TME.
  • The strength of cGAS/STING activation correlates with type 1 interferon and cytokine production.
  • Dysregulation of cGAS/STING in MICs contributes to tumor progression.

Conclusions:

  • Modulating MIC-specific cGAS/STING signaling is a promising avenue for cancer immunotherapy.
  • Targeting cGAS/STING can reprogram the TIME to enhance anti-tumor immunity.
  • Understanding cGAS/STING pathways in MICs is critical for developing novel cancer treatments.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.7K